Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 700 participants.
Also called NCT06791629
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 700 participants
- Sponsor
- Registry
-
NCT06791629
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06791629. Randomized; no masking; primary purpose treatment. Start 2025-02-15 (anticipated); primary completion 2026-12-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation
- Acronym
- PRAISE
- Condition
- Persistent Atrial Fibrillation
- Condition
- Radiofrequency Catheter Ablation
- Condition
- Pulsed Field Ablation
- Intervention (Device)
- Pulsed Field Ablation
- Intervention (Device)
- Radiofrequency Ablation
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct06791629- Content hash
cdc7ec2896d152f73738084bf4b044722ee986c3efffecbaf5937720bbe8222a